Close Menu

Not Enough Training

"Today's trainees are sold promises that their hard work in the lab will pay off with tenure-track positions in academia," writes the American Society for Biochemistry and Molecular Biology's Benjamin Corb in a post at the organization's News From the Hill blog. "Nearly one in three biomedical PhDs will end up with a career in the private sector, and yet our community rarely if ever provides training to PhDs that will both prepare them for alternative careers and educate them on realistic employment options that will be available."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.